Concepedia

Author

J Anderson

Royal Perth Hospital

Also Known As

J Anderson, J E Anderson, J. ANDERSON, J. Anderson, J. E. ANDERSON, J. E. Anderson, J. E. M. ANDERSON, J. E. M. Anderson, J.E Anderson, JEM Anderson

26

Publications

1K

Citations

10

H-Index

19

Concepts

All Affiliations

Royal Perth HospitalUniversity of Nebraska Medical Center
JA

About

J Anderson is an author at Royal Perth Hospital specializing in medicine, pathology, and pharmacokinetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

567

2

Pathology

2

2

548

3

Biostatistics

1

1

19

4

Gastroenterology

1

1

522

5

Nephrology

1

1

19

J Anderson

×

9

Publications

884

Citations

9

H-Index

YearCitations

Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

Bruce N. Gray, Guy van Hazel, MD Thomas A. Hope,

Annals of Oncology

2001

522

REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERES

Bruce N. Gray, J Anderson, Mark A. Burton,

Australian and New Zealand Journal of Surgery

1992

143

Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rate

Bruce N. Gray, Mark A. Burton, D K Kelleher,

Journal of Surgical Oncology

1989

88

Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.

Azra Raza, Sefer Gezer, J Anderson,

PubMed

1992

28

Unrelated and HLA‐Nonidentical Related Donor Marrow Transplantation forThalassemia and Leukemia: A Combined Report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry<sup>a</sup>

Keith M. Sullivan, Claudio Anasetti, M. Horowitz,

Annals of the New York Academy of Sciences

1998

27

Intracerebral malignant fibrous histiocytoma: a light and electron microscopic study with immunohistochemistry.

Roderick H.W. Simpson, J. I. Phillips, Patricia E. Miller,

PubMed

1987

26

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.

Julie M. Vose, Arundathy Pandite, Roy Beveridge,

Journal of Clinical Oncology

1997

21

Evaluation of a Bayesian Approach to the Pharmacokinetic Interpretation of Cyclosporin Concentrations in Renal Allograft Recipients

J Anderson, Angela Munday, A. W. Kelman,

Therapeutic Drug Monitoring

1994

19

Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.

J. M. Vose, J Anderson, P. J. Bierman,

Journal of Clinical Oncology

1996

10

Page 1